6 Related NICE guidance
6.1 NICE has issued the following related technology appraisals.
-
Capecitabine for the treatment of locally advanced and metastatic breast cancer. NICE technology appraisal guidance 62 (2003). [Replaced by NICE clinical guideline 81]
-
Vinorelbine for the treatment of advanced breast cancer. NICE technology appraisal guidance 54 (2002). [Replaced by NICE clinical guideline 81]
-
Trastuzumab for the treatment of advanced breast cancer. NICE technology appraisal guidance 34 (2002).
-
Taxanes for the treatment of breast cancer. NICE technology appraisal guidance 30 (2001). [Replaced by NICE clinical guideline 81]
-
Breast cancer (advanced). NICE clinical guideline 81 (2009).